PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE)
Key facts
- Who runs it
- Singapore General Hospital
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Feb 2026
- Expected to end
- Mar 2027
- Type of study
- Interventional
- Treatments tested
- CarbonCool® Cooling Vest
- Record updated
- 29 April 2026
Who can take part
- Age
- 16 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Out-of-hospital cardiac arrest (OHCA) of any rhythm attended by Singapore Civil Defence Force (SCDF) paramedics
- Return of spontaneous circulation (ROSC) achieved in the pre-hospital setting
- Age ≥16 years and ≤80 years
- Patient remains comatose after ROSC, with Glasgow Coma Scale (GCS) ≤8
Who cannot take part
- Traumatic cause of cardiac arrest
- Age >80 years
- Tympanic temperature <34°C at time of assessment
- Pregnant females
- Termination of resuscitation in the Emergency Department
- Withdrawal of life support within 24 hours of Coronary Care Unit (CCU) admission
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 16 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE) study is a pilot feasibility trial evaluating the implementation of pre-hospital targeted temperature management (TTM) using a wearable surface cooling device (CarbonCool® vest) in adult out-of-hospital cardiac arrest (OHCA) patients with return of spontaneous circulation (ROSC). The study aims to assess feasibility, fidelity, acceptability, and safety of initiating cooling in the field by emergency medical services (EMS) prior to hospital arrival. Results will inform the design of a larger definitive trial to determine the clinical effectiveness of early pre-hospital TTM in improving neurological outcomes.
The group in the trial
- Pre-hospital Targeted Temperature ManagementTreatment being tested
Eligible out-of-hospital cardiac arrest (OHCA) patients who achieve return of spontaneous circulation (ROSC) and meet inclusion criteria will receive early targeted temperature management (TTM) initiated in the pre-hospital setting by Singapore Civil Defence Force (SCDF) paramedics. Cooling is delivered using the CarbonCool® surface cooling vest, applied immediately after ROSC and maintained during transport to the receiving hospital. Upon hospital arrival, a 1-for-1 vest exchange is performed in the Emergency Department before continuation of standard post-cardiac arrest care.
Treatment: CarbonCool® Cooling Vest
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE): a Pilot Feasibility Study
- Criteria questions
- Built from NCT07421882, who can take part
- Record updated
- 29 April 2026